Immunology of Neuroblastoma. Beyond the Immunotherapy

被引:0
|
作者
Druy, A. [1 ,2 ]
Andreeva, N. [1 ]
Shamanskaya, T. [3 ]
Kachanov, D. [3 ]
机构
[1] Dmitry Rogachev Natl Med Res Ctr Pediat Hematol O, Mol Oncol Lab, Moscow, Russia
[2] Res Inst Med Cell Technol, Lab Cellular Therapy Oncohematol Disorders, Ekaterinburg, Russia
[3] Dmitry Rogachev Natl Med Res Ctr Pediat Hematol O, Dept Clin Oncol, Moscow, Russia
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
0631
引用
收藏
页码:S285 / S285
页数:1
相关论文
共 50 条
  • [1] Immunology and immunotherapy of neuroblastoma
    Seeger, Robert C.
    SEMINARS IN CANCER BIOLOGY, 2011, 21 (04) : 229 - 237
  • [2] Patterns of relapse after immunotherapy in patients with high-risk neuroblastoma.
    Moerdler, Scott
    Naranjo, Arlene
    Tenney, Sheena
    Bagatell, Rochelle
    Yu, Alice L.
    London, Wendy B.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] Catecholamine cardiomyopathy in neuroblastoma.
    Joseph, T
    Olivier, B
    Magnier, S
    Brugieres, L
    Casasoprana, A
    ARCHIVES DE PEDIATRIE, 1997, 4 (01): : 32 - 35
  • [4] Antibody Therapy and Neuroblastoma.
    Tao, Xiaohua
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (03): : 289 - 289
  • [5] Metabolic characterization of neuroblastoma.
    Goodwill, T
    Shulkin, BL
    Schumacher, K
    Devooght, J
    Castle, V
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 36P - 37P
  • [6] Addition of chemo-immunotherapy to standard induction chemotherapy for high-risk neuroblastoma.
    Fernandez, Karen S.
    Sabnis, Amit J.
    Titapiwatanakun, Ruetima
    Baker, Katherine
    Tcheng, Wendy
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Temozolomide in resistant or relapsed neuroblastoma.
    Donfrancesco, A
    Milano, GM
    Jenkner, A
    de Sio, L
    Fidani, P
    Ilari, I
    Cozza, R
    Castellano, A
    de Laurentis, C
    Dominici, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 805S - 805S
  • [8] IMAGES IN EMERGENCY MEDICINE Neuroblastoma.
    Lipsett, Susan C.
    ANNALS OF EMERGENCY MEDICINE, 2017, 69 (06) : 688 - +
  • [9] Molecular mechanisms for telomere maintenance in neuroblastoma.
    Bahrami, Armita
    Lee, Seungjae
    Fan, Yiping
    Morris, John
    Pappo, Alberto S.
    Furman, Wayne Lee
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [10] Preclinical study of a PARP inhibitor in neuroblastoma.
    Addioui, Anissa
    Belounis, Assila
    Cournoyer, Sonia
    Nyalendo, Carine
    Brito, Rose-Marie
    Beaunoyer, Mona
    Teira, Pierre
    Sartelet, Herve
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)